As Diaverum, one of the big five global dialysis operators, gears up for a $1bn-plus sale in 2019, what is the future of the only health care service which is truly internationalised?
What really makes a healthcare brand stand out and succeed? And how do operators actually achieve this? At HBI 2019 we heard from an operational expert at Siemens Healthineers, a marketing expert from one of the UK's largest private hospital groups and were given a financial steer on branding from Turkish hospital group MLP Care.
Turkey's largest independent private hospital group wants to consolidate the market by buying 9% of the country's for-profit hospitals over the next 2-3 years.
Pan-Asian hospital group IHH Healthcare saw 3% revenue growth, 9% EBITDA growth but a 35% plummet in post-tax profits in 2018. The results confirm its struggles in Turkey.
We hear that a handful of independent private hospitals in Turkey have closed in the past few months as a faltering economy takes its toll, while larger groups are apparently cutting back on staffing to maintain margins.
A month ago we wrote that pan-Asian hospital group IHH Healthcare might be looking to exit its Turkish subsidiary, Acibadem. Over the past week, it revealed a loss in Q3 because of the Lira's fall and also announced a new single-largest shareholder. One source suggests it might be looking to sell before March's local elections in Turkey.
Recent developments point to pan-Asian hospital group IHH scaling down Acibadem, its Turkey-based subsidiary. What does this mean for its interest in Europe? We talk to well-placed sources about what a falling lira, shareholder restructuring, asset sales in Bulgaria and Macedonia, and IHH’s acquisition of Indian chain Fortis might mean.
Recent developments point to pan-Asian hospital group IHH scaling down Acibadem, its Turkey-based subsidiary. What does this mean for its interest in Europe? We talk to well-placed sources about what a falling lira, shareholder restructuring, asset sales in Bulgaria and Macedonia, and IHH's acquisition of Indian chain Fortis might mean.
The CEOs of Siemens, Uber, Japan’s biggest bank and the US Treasury secretary pulled out of a conference in Saudi Arabia which started yesterday, in light of journalist Jamal Khashoggi’s death. Might this dampen international appetite for taking part in crown prince Mohammed Bin Salman’s healthcare reform process? Turkish president Erdogan yesterday branded the killing […]
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
